RATIONAL THERAPY OF OSTEOARTHRITIS IN OUTPATIENT CONDITIONS

RATIONAL THERAPY OF OSTEOARTHRITIS IN OUTPATIENT CONDITIONS

Show other versions (1)

<p><strong>Aim.</strong> To evaluate in the comparative aspect of the symptomatic effectiveness of therapy chondroitin sulfate and it’s combination with glucosamine hydrochloride in patients with osteoarthritis in outpatient conditions and determine the most rational scheme of the...

Full description

Bibliographic Details
Main Authors:	E. E. Savelova, O. Yu. Maiko
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Klinicist
Subjects:	остеоартроз хондроитина сульфат глюкозамина гидрохлорид
Online Access:	http://klinitsist.abvpress.ru/index.php/Klin/article/view/59

Similar Items

RATIONAL THERAPY OF OSTEOARTHRITIS IN OUTPATIENT CONDITIONS
by: E. E. Savelova, et al.
Published: (2014-07-01)

THE CORES A SYMPTOM-MODIFYING PREPARATIONS OF THE SLOWEDDOWN ACTION IN THERAPY OF OSTEOARTROSIS
by: V V Badokin, et al.
Published: (2010-04-01)

Coxarthrosis and periarticular pathology of the hip: clinical manifestations, diagnosis, approaches to therapy
by: Nadezhda Aleksandrovna Shostak
Published: (2012-03-01)

COMBINATION THERAPY IN THE TREATMENT OF OSTEOARTHRITIS. THE EFFECTIVENESS OF THERAFLEX
by: L I Alekseeva
Published: (2012-12-01)

Russian experience with injectable chondroitin sulfate and glucosamine sulfate: a review of clinical trials
by: A. E. Karateev, et al.
Published: (2018-04-01)

Basic symptom-modifying delayed-action drugs in therapy of osteoporosis
by: Vladimir Vasil'evich Badokin, et al.
Published: (2011-09-01)

Chondroitin sulfate: the mechanisms of action, its efficacy and safety in the therapy of osteoarthrosis
by: S G Anikin, et al.
Published: (2012-09-01)

Knee osteoarthrosis: Clinical presentation, diagnosis, treatment
by: Vladimir Vasilyevich Badokin
Published: (2013-10-01)

Standardised Forms of Chondroitin Sulfate as a Pathogenetic Treatment of Osteoarthritis in the Context of Post-Genomic Studies
by: O. A. Gromova, et al.
Published: (2021-02-01)

Treatment in patients with osteoarthritis at different sites: Place of slow-acting drugs
by: N. V. Chichasova, et al.
Published: (2015-06-01)

On the prospects for the use of undenatured type II collagen in the treatment of osteoarthritis and other joint diseases
by: O. A. Gromova, et al.
Published: (2022-08-01)

The efficacy and tolerability of the slow-acting combined agent glucosamine and chondroitin sulfate in gonarthrosis patients tacking no nonsteroidal anti-inflammatory drugs
by: A. P. Rebrov, et al.
Published: (2016-01-01)

Step-by-step therapy with chondroitin sulfate in patients with osteoarthritis in an outpatient setting
by: L. V. Vasilyeva, et al.
Published: (2017-09-01)

Modern aspects of the pathogenetic therapy of osteoarthritis
by: V. V. Badokin
Published: (2013-12-01)

Hand osteoarthritis: pathogenesis, diagnosis, and approaches to therapy
by: N. A. Shostak, et al.
Published: (2019-10-01)

Combination drugs in treatment of osteoarthrosis. Efficacy of Theraflex
by: L. I. Alekseyeva
Published: (2013-12-01)

Pharmacoinformation studies of chondroprotectors
by: A. M. Lila, et al.
Published: (2021-10-01)

Current possibilities of pharmacological correction of neuroimmune joint damage in patients with knee osteoarthritis in long COVID conditions
by: I. V. Sarvilina, et al.
Published: (2022-06-01)

Important aspects of osteoarthritis therapy during the COVID-19 pandemic
by: A. M. Lila, et al.
Published: (2022-02-01)

The use of injectable chondroitin sulfate in combination with dosed physical exercise for the treatment of patients with hand osteoarthritis
by: L. V. Vasilyeva, et al.
Published: (2020-09-01)

Evidence-based therapy for knee osteoarthritis: expected short-, medium-, and long-term outcomes of prescription crystalline glucosamine sulfate administration
by: L. N. Denisov, et al.
Published: (2022-08-01)

Cardiovascular safety and efficacy of the combined symptomatic slow-acting drug glucosamine and chondroitin sulfate in patients with gonarthrosis
by: A. P. Rebrov, et al.
Published: (2016-06-01)

Treatment of pain in patients with osteoarthritis of different location
by: N. V. Chichasova
Published: (2014-12-01)

Comparative clinical and economic analysis of the use of symptomatic slow-acting drugs containing glucosamine sulfate in patients with Stage II gonarthrosis during outpatient care
by: I. V. Sarvilina, et al.
Published: (2019-12-01)

DEVELOPMENT OF TECHNOLOGY AND METHODS OF CONTROL OF BIFUNCTIONAL OINTMENT
by: K. R. Saveleva, et al.
Published: (2019-01-01)

Morphological reflection of highly purified chondroitin sulfate action in patients with decompensated form of knee osteoarthritis
by: T. B. Minasov, et al.
Published: (2022-12-01)

Evaluation of the efficacy and safety of a combination of chondroitin sulfate and glucosamine sulfate for knee and hip osteoarthritis in real clinical practice
by: A. E. Karateev, et al.
Published: (2020-11-01)

On the anticoagulant and antiaggregatory properties of a glucosamine sulfate molecule
by: I. Yu. Torshin, et al.
Published: (2019-09-01)

The results of postgenomic analysis of a glucosamine sulfate molecule indicate the prospects of treatment for comorbidities
by: I. Yu. Torshin, et al.
Published: (2018-12-01)

Symptom-modifying slow-acting drugs in the treatment of osteoarthritis: from molecule to clinical effect (a pharmacologist's view)
by: A. S. Dukhanin
Published: (2018-06-01)

Osteoarthritis: Key elements in its pathogenesis and current agents for pathogenetic therapy
by: Yu. A. Olyunin, et al.
Published: (2017-09-01)

Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs
by: E. V. Zonova
Published: (2021-04-01)

Efficacy of Chondroitin Sulfate in Patients with Knee and Hip Osteoarthritis
by: E. P. Sharapova, et al.
Published: (2021-08-01)

Effects of modern chondroprotectors in osteoarthritis
by: V. V. Kosarev, et al.
Published: (2014-12-01)

Chemoreactome analysis of the antithrombotic effects of glucosamine sulfate and nonsteroidal anti-inflammatory drugs
by: O. A. Gromova, et al.
Published: (2019-03-01)

The place of chondroprotectors in the treatment of osteoarthritis of the spine
by: N. V. Pizova
Published: (2016-12-01)

Differential chemoreactome analysis of glucosamine sulfate and non-steroidal anti-inflammatory drugs: promising synergistic drug combinations
by: O. A. Gromova, et al.
Published: (2018-06-01)

DEVELOPMENT OF METHOD FOR DETERMINATION OF INTRINSIC VISCOSITY OF INJECTABLE DRUG WITH CHONDROITIN SULFATE
by: K. R. Saveleva, et al.
Published: (2019-01-01)

Evaluation of the effect of chronic pain on the functional and physical status of patients in older age groups
by: A. V. Naumov, et al.
Published: (2021-12-01)

Дослідження впливу комбінованого застосування L-тироксину (левотироксину), диклофенаку натрію та хондроітину сульфату на гістологічну структуру хрящової тканини при гіпотиреозі та остеоартрозі.
by: D. S. Nosivets, et al.
Published: (2019-06-01)